Uncategorized
Serious health threats possible with underregulated commercial stem cell clinics
Stem cells hold potential benefits for the treatment of age-related macular degeneration, but commercial stem cell clinics that skirt under FDA regulations and oversights can pose serious health threats to patients, according to an editorial in the New England Journal of Medicine. Two articles, one by Mandai and colleagues and the other by Kuriyan and colleagues, which Ocular Surgery News previously reported about, describe different stem cell approaches for the treatment of AMD, George Q. Daley, MD, PhD, wrote. Mandai and colleagues describe the treatment of a woman with AMD (Read more...)